Project cooperationUpdated on 28 April 2026
Population-based molecular epidemiology partner with access to patient cohorts and biospecimen collection for cancer and exposure research
Associate Professor at Nofer Institute of Occupational Medicine
Lodz, Poland
About
We are a multidisciplinary team at Nofer Institute of Occupational Medicine specialising in molecular epidemiology, exposure science and biomarker-based risk assessment.
Our key strengths:
-
access to well-characterised populations: cancer patients (including FFPE tissues), individuals with chronic diseases, occupationally exposed groups and general population cohorts
-
biological sampling and biobanking (blood, urine, FFPE) with clinical and exposure data linkage
-
molecular analyses: DNA/RNA methylation, gene expression (qPCR/dPCR), telomere length, oxidative stress markers
-
exposure assessment: environmental and occupational data integration (e.g. air pollution, water contaminants)
We offer strong added value to consortia through:
-
recruitment of patients and population groups,
-
high-quality biospecimens and data,
-
laboratory analyses including markers of exposure and effects
We are interested in projects on cancer, exposome, environmental and occupational health, biomarkers and early detection.
Topic
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
Organisation
Similar opportunities
Project cooperation
Clinical collaboration for thyroid cancer and thyroid disease biospecimen collection
- Offering Expertise to Consortias
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Fabio Medas
Associate Professor of Surgery, University of Cagliari at University of Cagliari
Cagliari, Italy
Project cooperation
Implementation Partner for Horizon Europe Health Cluster & Mission Cancer Projects
- Offering Expertise to Consortias
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
Nezihe Tugba Tunckaya Celik
Occupational Physician at Sincan District Health Directorate
Ankara, Türkiye
Project cooperation
Vascular Biology and Tumor Microenvironment Expertise for Translational Cancer Projects
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- Ideation - identifying the project idea
- Drafting - writing the project proposal
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Melissa Garcia Caballero
Distinguished Researcher /Associate Professor/ Principal Investigator at University of Málaga - IBIMA.BIONAND Platform
Málaga, Spain